Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein-Reference-Cited by-同舟云学术

Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein

Published:1993-01 Issue:3 Volume:29 Page:408-415
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Barrand M.A.,Rhodes T.,Center M.S.,Twentyman P.R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. P-glycoprotein: multidrug resistance and a superfamily of membrane-associated transport proteins;Juranka;FASEB J,1989

2. Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein;McGrath;Biochem Biophys Res Commun,1987

3. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line;Zijlstra;Cancer Res,1987

4. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to vinca alkaloids independent of P-glycoprotein;Haber;Cancer Res,1989

5. Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells;Hindeburg;Cancer Res,1989

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A macrocyclic peptide inhibitor traps MRP1 in a catalytically incompetent conformation;Proceedings of the National Academy of Sciences;2023-03-09

2. Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum‐based doublet chemotherapy;Journal of Biochemical and Molecular Toxicology;2022-12-11

3. The emergence of nanoporous materials in lung cancer therapy;Science and Technology of Advanced Materials;2022-07-20

4. A critical review on modulators of Multidrug Resistance Protein 1 in cancer cells;PeerJ;2022-01-05

5. Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition;Drug Resistance Updates;2021-12